Get startedLog in
    Picture of Burning Rock Biotech logo

    BNR — Burning Rock Biotech Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue430508563537516
    Cost of Revenue
    Gross Profit314364380363362
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Total Operating Expenses8421,3051,5441,207873
    Operating Profit-412-797-980-669-358
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-407-796-969-651-341
    Provision for Income Taxes
    Net Income After Taxes-407-797-971-654-347
    Net Income Before Extraordinary Items
    Net Income-407-797-971-654-347
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-472-797-971-654-347
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-68.8-76.5-93.5-63.8-3.15